These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20671873)

  • 1. Prothrombin complex concentrates: an update.
    Franchini M; Lippi G
    Blood Transfus; 2010 Jul; 8(3):149-54. PubMed ID: 20671873
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrospective evaluation of the clinical use of prothrombin complex concentrate for the reversal of anticoagulation with vitamin K antagonists.
    Cruz JL; Moss MC; Chen SL; Hansen KM; Amerine LB
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):378-82. PubMed ID: 25688457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study.
    Sølbeck S; Nilsson CU; Engström M; Ostrowski SR; Johansson PI
    Scand J Clin Lab Invest; 2014 Oct; 74(7):591-8. PubMed ID: 24909158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin complex concentrates in emergency bleeding disorders.
    Rodgers GM
    Am J Hematol; 2012 Sep; 87(9):898-902. PubMed ID: 22648513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
    Perzborn E; Heitmeier S; Laux V; Buchmüller A
    Thromb Res; 2014 Apr; 133(4):671-81. PubMed ID: 24529498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department.
    Díaz MQ; Borobia AM; Núñez MA; Virto AM; Fabra S; Casado MS; García-Erce JA; Samama CM
    Haematologica; 2013 Nov; 98(11):e143-4. PubMed ID: 24186317
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of coagulation markers and 4F-PCC-mediated reversal of rivaroxaban in a rabbit model of acute bleeding.
    Herzog E; Kaspereit F; Krege W; Mueller-Cohrs J; Doerr B; Niebl P; Dickneite G
    Thromb Res; 2015 Mar; 135(3):554-60. PubMed ID: 25619440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-factor prothrombin complex concentrate reverses apixaban-associated bleeding in a rabbit model of acute hemorrhage.
    Herzog E; Kaspereit F; Krege W; Mueller-Cohrs J; Doerr B; Niebl P; Dickneite G
    J Thromb Haemost; 2015 Dec; 13(12):2220-6. PubMed ID: 26447393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin, alone or in complex concentrates or plasma, reduces bleeding in a mouse model of blood exchange-induced coagulopathy.
    Eltringham-Smith LJ; Yu R; Qadri SM; Wang Y; Bhakta V; Pryzdial EL; Crosby JR; Ni H; Sheffield WP
    Sci Rep; 2019 Sep; 9(1):13029. PubMed ID: 31506556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation.
    Endres K; St Bernard R; Chin-Yee I; Hsia C; Lazo-Langner A
    Hematology; 2020 Dec; 25(1):489-493. PubMed ID: 33317427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding.
    Schick KS; Fertmann JM; Jauch KW; Hoffmann JN
    Crit Care; 2009; 13(6):R191. PubMed ID: 19948037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study.
    Smith MN; Deloney L; Carter C; Weant KA; Eriksson EA
    J Thromb Thrombolysis; 2019 Aug; 48(2):250-255. PubMed ID: 30941571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of dabigatran-induced bleeding by coagulation factor concentrates in a rat-tail bleeding model and lack of effect on assays of coagulation.
    van Ryn J; Schurer J; Kink-Eiband M; Clemens A
    Anesthesiology; 2014 Jun; 120(6):1429-40. PubMed ID: 24714118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation factor concentrates and point-of-care coagulation monitoring: both might be essential for optimal treatment of trauma-induced coagulopathy.
    Grottke O; Rossaint R
    Lancet Haematol; 2017 Jun; 4(6):e246-e247. PubMed ID: 28457981
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of Warfarin Reversal with 4-Factor Prothrombin Complex Concentrate Compared to 3-Factor Prothrombin Complex Concentrate at a Tertiary Academic Medical Center.
    Al-Majzoub O; Rybak E; Reardon DP; Krause P; Connors JM
    J Emerg Med; 2016 Jan; 50(1):7-13. PubMed ID: 26433428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of the prothrombin complex concentrate dose for warfarin reversal.
    Makris M
    Thromb Res; 2005; 115(6):451-3. PubMed ID: 15792674
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversal of warfarin associated coagulopathy with 4-factor prothrombin complex concentrate in traumatic brain injury and intracranial hemorrhage.
    Yanamadala V; Walcott BP; Fecci PE; Rozman P; Kumar JI; Nahed BV; Swearingen B
    J Clin Neurosci; 2014 Nov; 21(11):1881-4. PubMed ID: 24953825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin complex concentrate and fatal thrombosis: poor evidence to implicate a relatively safe drug.
    Sarode R; Matevosyan K
    Ann Emerg Med; 2009 Sep; 54(3):481-2; author reply 482-3. PubMed ID: 19695429
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversing Dabigatran Anticoagulation with Prothrombin Complex Concentrate versus Idarucizumab as Part of Multimodal Hemostatic Intervention in an Animal Model of Polytrauma.
    Honickel M; Braunschweig T; Rossaint R; Stoppe C; Ten Cate H; Grottke O
    Anesthesiology; 2017 Nov; 127(5):852-861. PubMed ID: 28857806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy Using Prothrombin Complex Concentrate and Vitamin K in Anticoagulated Patients with Traumatic Intracranial Hemorrhage Prevents Progressive Hemorrhagic Injury: A Historically Controlled Study.
    Koyama H; Yagi K; Hara K; Matsubara S; Tao Y; Uno M
    Neurol Med Chir (Tokyo); 2021 Jan; 61(1):47-54. PubMed ID: 33208582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.